J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
The Journal of Clinical Pharmacology and the Journal of New Drugs, 1969; 9:104-117
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gold, H.
Right arrow Articles by Goessel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gold, H.
Right arrow Articles by Goessel, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pseudo-Intractable Heart Failure With Edema: Some of the Mechanisms and Means for Restoring Response to Treatment

Harry Gold M.D.1, Nathaniel T. Kwit M.D.1, Argyrios J. Golfinos M.D.2, Charles R. Messeloff M.D.1, William Zahm M.D.1, and Elizabeth Goessel M.D.1

1 Cornell University Medical College; the Hospital for Joint Diseases and Medical Center; Beth Israel Medical Center, New York, N.Y.
2 Cornell University Medical College; the Hospital for Joint Diseases and Medical Center; Beth Israel Medical Center, New York, N.Y.

Pseudo-intractable heart failure is distinguished from true intractable heart failure by the fact that, while both develop resistance to treatment by the conventional measures, the former yields to one or another regimen of treatment, the latter yields to none and is due to factors that are irreversible.

We have described a variety of cases of pseudo-intractable failure and the methods by which the apparently intractable failure is reversed.

A regimen including a salt-restricted diet in the form of 3 liters of milk and water in equal amounts, digitalization, and a daily injection of 2 cc meralluride or mercaptomerin reverses the vast majority of cases of so-called pseudo-in-tractable failure.

The two types of failure can usually be distinguished in a few days by the response to a therapeutic trial of the new diuretic regimen. If a weight loss occurs 24 hours after the first or second daily 2-cc injection of the mercurial, the patient is one of reversible or pseudo-in-tractability. If in the absence of a manifest obstacle, the patient fails in this challenge, the case is one of true, or irreversible, intractable failure not likely to yield to any form of antifailure treatment.

Pressure from massive ascites can impair the renal circulation and make a pseudo-intractable failure react like true irreversible intractability. Abdominal paracentesis can restore the response to the mercurial diuretic.

Surreptitious salt intake is a pitfall in the human pharmacology of diuresis. Pseudo-intractable (reversible) failure can assume thereby the behavior pattern of true (irreversible) intractable failure.

Response to a diuretic agent has a diphasic pattern, a diuretic response associated with an antidiuretic reaction. A patient with edema, very sensitive to the diuretic action, and with a dominant antidiuretic reaction, may disclose the paradox of little or no clearing of edema in one with vigorous reactions to individual doses of the diuretic.

A series of similar daily doses of a diuretic, however short, shows declining diuretic responses even in the presence of abundant edema. In a very sensitive patient, even one dose causing a massive diuresis may be followed by suppression of response to subsequent daily doses. We assume these phenomena to be due to adrenal antidiuretie factors.

The decline or suppression of the diuretic response to a previous dose of the diuretic can be prevented by oral doses of spirolactone (Aldactone) and sometimes by other steroids.

Digitalis does not reverse pseudo-intractable heart failure since these patients are usually already fully digitalized.

A daily intramuscular dose of the organic mercurial is very effective in establishing response in pseudo-intractable failure. Several oral nonmercurials have been developed recently, some of considerable efficacy. It remains for clinical trial to determine whether they can take the place of the injectable mercurial in restoring response in cases of pseudo-intractable heart failure.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1969 by the American College of Clinical Pharmacology